Skip to main content
  • TMVr in Cardiogenic Shock with Significant MR May Improve Short-Term Mortality, Study Reports

    Transcatheter mitral valve repair (TMVr) using the MitraClip in patients with cardiogenic shock (CS) and moderate-to-severe or severe mitral regurgitation (MR) improved short-term mortality and heart failure rehospitalization rates, according to a pooled patient-level analysis of previously published studies released Monday.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details